SCHEMBL2811779

SCHEMBL2811779

c1cc(N2CCN(c3nc4c5c(n[nH]c5n3)CCN4)CC2)ccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.41
NCF1 P14598 1/20 0.41
PLD1 Q13393 1/20 0.41
CHKA P35790 1/20 0.37
GAA P10253 4/20 0.35
MAPT P10636 3/20 0.35
ALDH1A1 P00352 3/20 0.33
GFER P55789 1/20 0.33
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
PARP1 P09874 1/20 0.33
PIK3CA P42336 1/20 0.33
ROCK1 Q13464 1/20 0.32
PIM1 P11309 1/20 0.32
PIM3 Q86V86 1/20 0.32
CASP1 P29466 1/20 0.32
CASP4 P49662 1/20 0.32
CASP5 P51878 1/20 0.32
EED O75530 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13131427 0.78 HRH1 (0.38) ALDH1A1HTR2CCASP1CASP4CASP5
SCHEMBL2808533 0.77 PIK3CA (0.45) GAAMAPTALDH1A1HTR2AHTR2C
SCHEMBL537818 0.76 ALDH1A1 (0.40) GAAALDH1A1HTR2AHTR2CPIK3CA
SCHEMBL14407179 0.75 HRH1 (0.42) ALDH1A1HTR2AHTR2CROCK1CASP1
SCHEMBL13168278 0.74 CYP1A2 (0.42) MAPTHTR2A
SCHEMBL14405861 0.69 MAPT (0.48) GAAMAPTALDH1A1HTR2AHTR2C
SCHEMBL28112415 0.65 CHKA (0.80) ADRB2NCF1PLD1CHKAGAA
SCHEMBL537750 0.64 HTT (0.39) GAAMAPTALDH1A1HTR2AHTR2C
SCHEMBL12595271 0.64 HRH4 (0.56) ADRB2NCF1PLD1CHKAGAA
SCHEMBL2812440 0.63 HSD17B10 (0.42) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 ADRB2 3297/4885NCF1 1444/4885PLD1 2887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.